ISMRM25 - Bridging the Gap: Clinical Applications & Unmet Needs in Quantitative Susceptibility Mapping (QSM) of the Brain

ISMRM & ISMRT Annual Meeting & Exhibition • 10-15 May 2025 • Honolulu, Hawai'i

Bridging the Gap: Clinical Applications & Unmet Needs in Quantitative Susceptibility Mapping (QSM) of the Brain

Member-Initiated Session

Monday, 12 May 2025

313B

13:45 - 15:45

Moderators: Ferdinand Schweser, Beata Bachrata & Xu Li

Session Number: MIS-02

No CME/CE Credit

Overview:
This member-initiated session (MIS) is endorsed by the Electro-Magnetic Tissue Properties (EMTP) study group.

This symposium will explore current and potential clinical applications of Quantitative Susceptibility Mapping (QSM), primarily focusing on experiences from practicing clinicians who have implemented QSM in patient care. The session will address critical unmet clinical needs where QSM could provide impactful solutions based on real-world cases. Discussions will highlight how QSM has the potential to transform diagnosis and treatment in various diseases while identifying barriers to broader clinical adoption. The symposium will also include vendor presentations that provide updates on the status of QSM packages. This MIS aims at guiding both the ISMRM community and industry stakeholders on the most promising clinical and unmet needs, helping to accelerate the development and deployment of QSM technologies in clinical settings.

Target Audience:
Clinicians and anyone else who is interested in clinical applications of QSM.

Learning Objectives:
Upon completion of this activity, participants should be able to:
• Summarize clinical applications of QSM from a practitioner’s perspective: Attendees will hear from clinicians who have used QSM in real-world patient care, learning about its impact on diagnosis and treatment;
• Identify unmet clinical needs that QSM could address: Participants will explore areas where QSM has the potential to fill gaps in current clinical practice, with a focus on diseases that require quantitative imaging techniques;
• Gain insights into challenges and opportunities for broader clinical adoption of QSM: Through case studies and clinician presentations, attendees will learn about the key hurdles that need to be overcome for QSM to become widely adopted in clinical care; and
• Help guide future development of QSM technologies: The session will provide valuable insights to both methods developers and industry, highlighting the most urgent needs that can be addressed rapidly through innovation and collaboration.

13:45		A Primer on QSM: A Conceptual Approach Without Equations Mauro Costagli
13:55		Multiple Sclerosis: QSM in the Diagnostic Criteria & Detection of Paramagnetic Rim Lesions Francesca Bagnato
14:07		Multiple Sclerosis: Insights from Diagnostic & Clinical Applications at a Single Center Lars Skattebol
14:19		Hemorrhage & Dementias Salil Soman
14:31		Alzheimer’s Disease: Microbleeds, Metabolic Dysfunction Gloria Chiang
14:43		ALS & Motor Neuron Diseases Luca Roccatagliata
14:55		SMWI in Parkinsonism Eung-Yeop Kim
15:07		Pediatric Neurology: From Birth Asphyxia to Sickle Cell Anemia Fenella Kirkham
15:19		Vendor Implementation: Canon Samir Sharma
15:25		Vendor Implementation: Philips Jakob Meineke
15:31		Vendor Implementation: Siemens Jin Jin
15:37		Vendor Implementation: United Imaging Yongguan Ye